CHD5 and breast carcinoma: Furthermore, knockdown of CHD5 in T-47D cells reduced the expression of the epithelial marker E-cadherin and increased the expression of mesenchymal marker vimentin (Figure 8E), suggesting that CHD5 loss could induce EMT in CHD5-positive breast cancer cells.